Cue Biopharma Payables and Accrued Expenses (Quarterly) Analysis

Cue Biopharma, Inc. (CUE)

0.3797 +0.01 (+4.08%) USD | NASDAQ | Jan 23, 16:00

0.375 0.00 (0.00%) After-Hours: 20:00

View Payables and Accrued Expenses (Quarterly) for CUE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Puma Biotechnology, Inc.	Upgrade
Adaptive Biotechnologies Corp.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade